Herman van Barneveld

Herman van Barneveld has over 14 years of experience in finance and operations roles. In 2021, they became the CFO of Stichting Hubrecht Organoid Technology and Chief Financial Officer of Momo Medical. In 2020, they were a Mentor at UtrechtInc Students and a Greyt Partner. From 2017 to 2021, they were an Independent Business Owner at HevaBa. Herman also became the Leidinggevende Financeafdeling of TargED Biopharmaceuticals in 2021 and Chief Financial Officer of FreshBed in 2020. From 2013 to 2011, they were the CFO/COO of Cipla and CFO Teva Pharmachemie & Region South of Teva Pharmaceuticals. From 2007 to 2011, they held various roles at GlaxoSmithKline, including Vice President Head of Programme Management Office, Vice President Acting Head Service Development Core Business Services, and Vice President, Head of PMO Core Business Services. Herman also held the role of Vice President Finance & CFO.

Herman van Barneveld attended HU University of Applied Sciences Utrecht (Hogeschool Utrecht) from 1983 to 1986, studying BE. Herman then attended Windesheim from 1990 to 1991. Finally, they attended Erasmus University Rotterdam from 1992 to 1994, graduating with a RA in Accountancy.